Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.58 Million CAD | 36.35% |
| 2022 | 9.22 Million CAD | 37.33% |
| 2021 | 6.71 Million CAD | 23.16% |
| 2020 | 5.45 Million CAD | 1.55% |
| 2019 | 5.37 Million USD | 26.12% |
| 2018 | 4.26 Million CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.41 Million CAD | 8.95% |
| 2024 Q1 | 4.05 Million CAD | 13.72% |
| 2023 Q2 | 3.12 Million USD | 13.29% |
| 2023 Q1 | 2.75 Million CAD | 5.35% |
| 2023 FY | 12.58 Million CAD | 36.35% |
| 2023 Q4 | 3.56 Million CAD | 24.89% |
| 2023 Q3 | 2.85 Million USD | -8.52% |
| 2022 Q3 | 2.29 Million CAD | -1.7% |
| 2022 Q2 | 2.33 Million CAD | 17.98% |
| 2022 Q1 | 1.97 Million CAD | 10.32% |
| 2022 FY | 9.22 Million CAD | 37.33% |
| 2022 Q4 | 2.61 Million CAD | 13.92% |
| 2021 Q2 | 1.63 Million CAD | 5.07% |
| 2021 Q3 | 1.73 Million CAD | 6.07% |
| 2021 Q4 | 1.79 Million CAD | 3.18% |
| 2021 FY | 6.71 Million CAD | 23.16% |
| 2021 Q1 | 1.56 Million CAD | 5.29% |
| 2020 FY | 5.45 Million CAD | 1.55% |
| 2020 Q4 | 1.48 Million CAD | -2.37% |
| 2020 Q3 | 1.51 Million CAD | 29.64% |
| 2020 Q2 | 1.17 Million CAD | -8.77% |
| 2020 Q1 | 1.28 Million CAD | -11.41% |
| 2019 Q2 | 1.43 Million CAD | 12.65% |
| 2019 Q4 | 1.44 Million CAD | 5.67% |
| 2019 Q1 | 1.27 Million CAD | 0.0% |
| 2019 Q3 | 1.37 Million CAD | -4.58% |
| 2019 FY | 5.37 Million USD | 26.12% |
| 2018 FY | 4.26 Million CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -1278.099% |
| Arrayit Corporation | 4.37 Million USD | -187.439% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 51.342% |
| Bioqual, Inc. | 58.59 Million USD | 78.526% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 17.743% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.83% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -97.638% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -1096.478% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 68.712% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -2711.637% |
| InVitro International | 792.62 Thousand USD | -1487.384% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -13.036% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -74.165% |
| NovelStem International Corp. | 12 Thousand USD | -104750.4% |
| Optigenex Inc. | 465.97 Thousand USD | -2600.184% |
| PharmChem, Inc. | 6.01 Million USD | -109.268% |
| Proteome Sciences plc | 6.4 Million USD | -96.575% |
| Response Genetics, Inc | 18.04 Million USD | 30.255% |
| Rennova Health, Inc. | 13.03 Million USD | 3.484% |
| RushNet, Inc. | 1.78 Million USD | -603.741% |
| ScreenPro Security Inc. | 1.91 Million USD | -557.334% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -231.536% |
| Todos Medical Ltd. | 7.69 Million USD | -63.509% |